Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-03 Boulding Mark Elliott EXEC. VP AND CLO Grant or award +18,000 110,389
2025-01-03 Boulding Mark Elliott EXEC. VP AND CLO Grant or award · Stock Option (Right to Buy) +45,000 45,000
2025-01-03 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Grant or award +19,000 106,048
2025-01-03 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Grant or award +715 6,137
2025-01-03 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Grant or award · Stock Option (Right to Buy) +47,500 47,500
2025-01-03 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Grant or award +20,000 80,659
2025-01-03 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-01-03 Pauwels Eric CHIEF EXECUTIVE OFFICER Grant or award +22,000 90,540
2025-01-03 Pauwels Eric CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +55,000 55,000
2025-01-03 Gravier Pierre CHIEF FINANCIAL OFFICER Grant or award +22,500 76,771
2025-01-03 Gravier Pierre CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +56,250 56,250
2025-01-03 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award +70,000 288,374
2025-01-03 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +175,000 175,000
2024-12-31 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −8,279 $45.16 $374K 217,528
2024-12-03 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +600 $33.02 $20K 92,989
2024-12-03 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −600 $53.04 $32K 92,389
2024-12-03 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +7,720 $33.02 $255K 100,109
2024-12-03 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −6,315 $53.14 $336K 93,794
2024-12-03 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −1,405 $54.05 $76K 92,389
2024-12-03 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +1,988 $33.02 $66K 94,377

Page 30 of 41 · 804 trades